Clinical Trial Update: A Study for PD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study investigating the PD-1 antibody JS001 in MSI-H advanced or recurrent colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• JS001 (PD-1 inhibitor)

Snippet

Sponsor: Xu jianmin | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN